Journey Medical Corporation to Participate in September 2026 Investor Conferences

ConferenceNeutral

AI Analysis

Summary

Journey Medical Corporation announced that Claude Maraoui, Co-Founder, President and CEO, will participate in two investor conferences in September 2026. This is a routine investor relations announcement with minimal market impact.

Importance:2/10

Sentiment:

0.00

investor conferencedermatologycommercial-stagemanagement

Related Companies

$DERM

Read the original article

Published by GlobeNewswire Pharma on September 8, 2026 8:05 PM

Read Original